Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 18:23:1093.
doi: 10.4102/sajpsychiatry.v23i0.1093. eCollection 2017.

Antipsychotic use in a resource-limited setting: Findings in an Eastern Cape psychiatric hospital

Affiliations

Antipsychotic use in a resource-limited setting: Findings in an Eastern Cape psychiatric hospital

Ingrid Eloff et al. S Afr J Psychiatr. .

Abstract

Background: Second-generation antipsychotics (SGAs) are commonly prescribed despite the fact that large, naturalistic studies have failed to show superior efficacy and tolerability when compared with first-generation antipsychotics (FGAs). In addition to this, the availability of SGAs in the South African public health sector is limited because of higher acquisition costs. Therefore, judicious use of FGAs, which are affordable and more widely available, should be considered.

Aims: This study aimed to (1) determine how frequently patients are switched from an FGA to an SGA in an acute psychiatric hospital in the Eastern Cape, (2) determine reasons for switching and (3) compare the profiles of the switch group to the non-switch group.

Method: The study is a cross-sectional survey conducted as a retrospective chart review at a psychiatric hospital in the Eastern Cape over a study period of 2 months. The demographics, diagnostic data, antipsychotic drug used and whether a switch from an FGA to an SGA took place were recorded using a data collection document. The sample included 169 patients.

Results: Of the 169 patients, 125 (74%) were initiated on an FGA and 44 (26%) on an SGA on admission. Of the 125 patients who were initiated on an FGA, 43 (34%) were switched to an SGA during the course of the admission. Therefore, 87 (51%) participants were discharged on an SGA. The main reasons for switching were the emergence of extrapyramidal side-effects (EPSE) (63%) followed by lack of efficacy (19%). The only statistically significant difference between the switch and non-switch groups was that the switch group was on average younger than the non-switch group.

Conclusion: SGAs, with the exception of clozapine, have not been proven to be superior to FGAs. Although FGAs are more prone to cause EPSE, SGAs carry significant risks of their own. FGAs are also more freely available and cost effective in South-Africa. Despite these facts the prescribing of and switching to SGAs remain prevalent in our setting with a switch rate of 34% and more than half of our patients being discharged on SGAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships which may have inappropriately influenced them in writing this article.

Figures

FIGURE 1
FIGURE 1
Antipsychotic initiated on admission.
FIGURE 2
FIGURE 2
Percentage of patients who remained on FGA and percentage of patients who were switched to SGA.
FIGURE 3
FIGURE 3
Patterns of antipsychotic use.
FIGURE 4
FIGURE 4
Reasons for switching from FGA to SGA.
FIGURE 5
FIGURE 5
Patterns of antipsychotic use, three distinct groups.
FIGURE 6
FIGURE 6
Diagnostic distribution of switch and non-switch groups.

References

    1. Abou-Setta AM, Mousavi SS, Spooner C, et al. . First-generation versus second-generation antipsychotics in adults. Comp Effect Rev. 2012;63:14–27. - PubMed
    1. Stahl SM. Stahl’s essential psychopharmacology. New York: Cambridge University Press; 2013; p. 626.
    1. Schatzberg AF, Nemeroff CB. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed [homepage on the Internet] 2009. [cited 2016 Jan18]. Available from: http://psychiatryonline.org/doi/book/10.1176/appi.books.9781585623860 - DOI
    1. Lewis S, Lieberman J. CATIE and CUtLASS: Can we handle the truth? Br J Psychiatry. 2008;192(3):161–163. 10.1192/bjp.bp.107.037218 - DOI - PubMed
    1. Lieberman JA, Stroup TS, McEvoy JP, et al. . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12):1209–1223. 10.1056/NEJMoa051688 - DOI - PubMed

LinkOut - more resources